A widely referenced review reports that GHK-Cu raises growth factors such as VEGF and is associated with larger follicles and better hair-transplant survival, though its author has a commercial affiliation, so it should be read as a mechanistic review rather than clinical proof (Pickart, 2008, DOI)
When Stable Schizophrenia was entered as a predictor, the R 2 of the model was 0.07, F (1, 71) = 5.332, p = 0.024, a small effect size, f 2 = 0.08
To summarize, on one hand the modest upwards trajectory of the obese and diabetic population provides a fertile ground for Pharma companies to sell more for the years to come, however, downside risks remain, including: pricing, compounders and overall competition, which will make it hard for companies like Novo and Lilly to maintain their growth
If you've been on Ozempic for several weeks and aren't seeing results, don't panic